Company GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. 12:35:10 2024-03-18 pm EDT 5-day change 1st Jan Change
1,661 GBX +0.68% Intraday chart for GSK plc -0.85% +14.52%

Business Summary

GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. Its vaccine portfolio includes more than 20 vaccines that help protect people from a range of diseases and infections throughout their lives. Its specialty medicines include medicines for immune-mediated conditions. Its specialty medicines are also engaged in developing medicines for respiratory disease and HIV. Its general medicines include inhaled medicines for asthma and chronic obstructive pulmonary disease (COPD), antibiotics, and medicines for skin diseases. The Company owns camlipixant, a selective P2X3 antagonist, which is in Phase III development for the treatment of refractory chronic cough (RCC).

Number of employees: 70,212

Sales per Business

GBP in Million2022Weight2023Weight Delta
Commercial Operations
100.0 %
29,324 100.0 % 30,328 100.0 % +3.42%

Sales per region

GBP in Million2022Weight2023Weight Delta
United States
52.2 %
14,542 49.6 % 15,820 52.2 % +8.79%
Rest of World
45.6 %
14,087 48.0 % 13,815 45.6 % -1.93%
United Kingdom
2.3 %
695 2.4 % 693 2.3 % -0.29%

Managers

Managers TitleAgeSince
Chief Executive Officer 55 10-04-30
Director of Finance/CFO 62 23-04-30
Compliance Officer - 95-07-31
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer - 17-12-31
Chief Tech/Sci/R&D Officer - 17-07-31
Director/Board Member 62 17-12-31
Corporate Officer/Principal 57 93-12-31
Corporate Officer/Principal - 10-08-31
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director of Finance/CFO 62 23-04-30
Chairman 66 19-08-31
Director/Board Member 65 14-12-31
Director/Board Member 62 17-12-31
Director/Board Member 57 22-07-17
Director/Board Member 58 23-09-30
Director/Board Member 65 20-04-30
Chief Executive Officer 55 10-04-30
Director/Board Member 67 22-08-31
Director/Board Member 73 15-12-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 4,372,918,804 4,022,932,329 ( 92.00 %) 255,885,366 ( 5.852 %) 92.00 %

Shareholders

NameEquities%Valuation
Gsk Plc Employee Share Ownership Trust
4.810 %
198,015,976 4.810 % 4 169 M p
The Vanguard Group, Inc.
3.770 %
155,190,000 3.770 % 3 268 M p
BlackRock Fund Advisors
2.897 %
119,251,464 2.897 % 2 511 M p
Dodge & Cox
2.414 %
99,377,874 2.414 % 2 093 M p
Norges Bank Investment Management
2.184 %
89,905,000 2.184 % 1 893 M p
Schroder Investment Management Ltd.
1.714 %
70,561,723 1.714 % 1 486 M p
BlackRock Advisors (UK) Ltd.
1.627 %
66,960,237 1.627 % 1 410 M p
Silchester International Investors LLP
1.618 %
66,609,000 1.618 % 1 403 M p
Mondrian Investment Partners Ltd.
1.242 %
51,138,382 1.242 % 1 077 M p
Legal & General Investment Management Ltd.
1.211 %
49,864,932 1.211 % 1 050 M p
NameEquities%Valuation
Dodge & Cox
3.354 %
69,026,793 3.354 % 2 892 M p
Fidelity Management & Research Co. LLC
0.9409 %
19,366,131 0.9409 % 811 M p
Fisher Asset Management LLC
0.7305 %
15,036,881 0.7305 % 630 M p
T. Rowe Price International Ltd.
0.6228 %
12,818,958 0.6228 % 537 M p
JTC Employer Solutions Trustee Ltd.
0.5995 %
12,340,190 0.5995 % 517 M p
PRIMECAP Management Co.
0.5873 %
12,089,370 0.5873 % 507 M p
RBC Private Counsel (USA), Inc.
0.4947 %
10,182,221 0.4947 % 427 M p
Eaton Vance Management
0.4155 %
8,552,173 0.4155 % 358 M p
Holocene Advisors, LP
0.3996 %
8,224,548 0.3996 % 345 M p
7,052,990 0.3427 % 296 M p
NameEquities%Valuation
Professionals’ Financial – Mutual Funds Inc.
0.000271 %
44,590 0.000271 % 590 553 p
Counsel Portfolio Services, Inc.
0.000190 %
31,235 0.000190 % 413 678 p
Matrix Capital Management Trust reg.
0.000034 %
5,600 0.000034 % 74 167 p

Holdings

NameEquities%Valuation
127,054,524 75.00% 3,328,359,698 $
385,320,110 4.17% 1,615,523,919 $
8,550,954 6.33% 96,112,723 $
76,161,378 91.20% 94,992,279 $
30,253,189 12.01% 88,339,312 $
263,029,794 82.59% 81,457,697 $
100,423,259 85.79% 76,469,299 $
13,983,761 11.75% 67,261,890 $
16,591,937 7.41% 56,744,425 $
707,859 8.06% 39,815,738 $

Company contact information

GSK Plc

980 Great West Road Brentford

TW8 9GS, Middlesex

+44 20 8047 5000

http://www.gsk.com
address GSK plc(GSK)

Group companies

NameCategory and Sector
GlaxoSmithKline Capital Plc
Finance/Rental/Leasing
Biotechnology
Miscellaneous Commercial Services
Beverages: Alcoholic
Pharmaceuticals: Major
Pharmaceuticals: Major
GlaxoSmithKline Finance Plc
Finance/Rental/Leasing
Financial Conglomerates
Pharmaceuticals: Major

Sales per Business

Sales per region

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
16.61 GBP
Average target price
19.8 GBP
Spread / Average Target
+19.24%
Consensus